Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) Dividend Yield, History & Forecast

Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 1.35% ($0.41 per share annually (TTM)). The most recent ex-dividend date was December 30, 2025, with payment scheduled for December 31, 2025. market capitalization is approximately $39M. Review OZEM dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

OZEM fund composition

OZEM holds 29 positions, with 69.1% of assets in its ten largest. It charges an expense ratio of 0.59%, and manages $55.9M.

Top 10 holdings

HoldingWeight
LLYEli Lilly & Co15.61%
NVONovo Nordisk A/S11.74%
PFEPfizer Inc8.26%
KLRAKailera Therapeutics Inc5.84%
1093.HKCSPC Pharmaceutical Group Ltd5.12%
4519.TChugai Pharmaceutical Co Ltd5.09%
AMGNAmgen Inc4.85%
VKTXViking Therapeutics Inc4.59%
AZNAstraZeneca PLC4.39%
128940.KSHanmi Pharm Co Ltd3.66%

Sector allocation

Healthcare100.0%Cash & Others0.8%Financial Services0.0%Technology0.0%

Frequently Asked Questions about Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM)

What is Roundhill Investments - GLP-1 & Weight Loss ETF's dividend yield?
Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) pays a current trailing twelve-month dividend yield of 1.35%, which works out to $0.41 per share annually based on the most recent payout schedule.
When does Roundhill Investments - GLP-1 & Weight Loss ETF pay distributions?
The most recent ex-dividend date was December 30, 2025. The next scheduled dividend payment date is December 31, 2025.
What does Roundhill Investments - GLP-1 & Weight Loss ETF invest in?
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.